CD79b targeting ADC with superior pharmacokinetic profile and anti-tumor activity.

被引:0
作者
Spycher, Philipp Rene [1 ]
Probst, Philipp [1 ]
Bertrand, Romain [1 ]
Stark, Ramona [1 ]
Santimaria, Roger [1 ]
Grabulovski, Dragan [1 ]
Attinger-Toller, Isabella [1 ]
机构
[1] Araris Biotech AG, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1842
引用
收藏
页数:1
相关论文
共 50 条
[21]   Preclinical pharmacology of ABT-518, a novel and potent inhibitor of gelatinase A and B with anti-tumor activity. [J].
Albert, DH ;
Morgan, DW ;
Magoc, T ;
Tapang, P ;
Kherzai, A ;
Marcotte, P ;
Elmore, I ;
Glaser, K ;
Pease, L ;
Li, J ;
Leal, J ;
Michaelides, M ;
Curtin, M ;
Holms, J ;
Wada, C ;
Dai, Y ;
Davidson, SK .
CLINICAL CANCER RESEARCH, 2000, 6 :4525S-4525S
[22]   IMMUNOMODULATORY EFFECTS OF MGD010, A DART® MOLECULE TARGETING HUMAN B-CELL CD32B AND CD79B [J].
Chen, W. ;
Shankar, S. ;
Lohr, J. ;
Yao, X. -T. ;
Li, H. ;
Chen, X. ;
Muth, J. ;
Gal-Edd, N. ;
Bonvini, E. ;
Johnson, S. ;
Pandya, N. ;
Moore, P. A. ;
Wigginton, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :777-778
[23]   CD62L+NKT cells have superior in vivo persistence and anti-tumor activity [J].
Tian, Gengwen ;
Courtney, Amy N. ;
Jena, Bipulendu ;
Heczey, Andras ;
Liu, Daofeng ;
Marinova, Ekaterina ;
Guo, Linjie ;
Xu, Xin ;
Dotti, Gianpietro ;
Cooper, Laurence J. ;
Metelitsa, Leonid S. .
JOURNAL OF IMMUNOLOGY, 2016, 196
[24]   A tumor microenvironment-targeting CD98-directed ADC confers robust anti-tumor activity in multiple cancers with favorable pharmacokinetics and safety profiles in preclinical models [J].
Yang, Fang ;
Wang, Lei ;
Tian, Xinxin ;
Qiu, Xuan ;
Chen, Jianhe ;
Qi, Wenke ;
Li, Guangyu ;
Liu, Haidong ;
Liu, Juan ;
Huang, Suping ;
Ye, Bin ;
Wu, Qilin ;
Zhao, Baiteng ;
Li, Wenhui ;
Sui, Jianhua ;
Chen, Zhu .
CANCER RESEARCH, 2024, 84 (07)
[25]   B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis [J].
Bruehl, Hilke ;
Cihak, Josef ;
Talke, Yvonne ;
Gomez, Manuel Rodriguez ;
Hermann, Fabian ;
Goebel, Nicole ;
Renner, Kerstin ;
Plachy, Jiri ;
Stangassinger, Manfred ;
Aschermann, Susanne ;
Nimmerjahn, Falk ;
Mack, Matthias .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (03) :705-715
[26]   Targeting macrophage anti-tumor activity to suppress melanoma progression [J].
Wang, Huafeng ;
Zhang, Lijuan ;
Yang, Luhong ;
Liu, Chengfang ;
Zhang, Qi ;
Zhang, Linjing .
ONCOTARGET, 2017, 8 (11) :18486-18496
[27]   SAFETY, TOLERABILITY, AND FUNCTIONAL ACTIVITY OF MGD010, A DART® MOLECULE TARGETING CD32B AND CD79B, FOLLOWING A SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS [J].
Pandya, N. ;
Chen, W. ;
Lohr, J. ;
Yao, X. -T. ;
Burns, R. ;
Li, H. ;
Li, H. ;
Muth, J. ;
Goldwater, R. ;
Bonvini, E. ;
Johnson, S. ;
Moore, P. ;
Wigginton, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 :132-133
[28]   Targeting CSK kinase activity to enhance anti-tumor immunity [J].
Wang, Cindy ;
Cao, Carolyn ;
Berman-Booty, Lisa ;
Swanson, Jesse ;
Eraslan, Rukiye ;
Sanjuan, Miguel ;
Vite, Gregory ;
Qin, Lan-Ying ;
Hunt, John ;
Fink, Bryan ;
Wee, Susan .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[29]   Combination of Camidanlumab Tesirine, a CD25-Targeted ADC, with Gemcitabine Elicits Synergistic Anti-Tumor Activity in Preclinical Tumor Models [J].
Jabeen, Asma ;
Huang, Shiran ;
Hartley, John A. ;
Van Berkel, Patrick H. ;
Zammarchi, Francesca .
BLOOD, 2020, 136
[30]   Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19 [J].
Ormhoj, Maria ;
Scarfo, Irene ;
Cabral, Maria L. ;
Bailey, Stefanie R. ;
Lorrey, Selena J. ;
Bouffard, Amanda A. ;
Castano, Ana P. ;
Larson, Rebecca C. ;
Riley, Lauren S. ;
Schmidts, Andrea ;
Choi, Bryan D. ;
Andersen, Rikke S. ;
Cedile, Oriane ;
Nyvold, Charlotte G. ;
Christensen, Jacob H. ;
Gjerstorff, Morten F. ;
Ditzel, Henrik J. ;
Weinstock, David M. ;
Barington, Torben ;
Frigault, Matthew J. ;
Maus, Marcela V. .
CLINICAL CANCER RESEARCH, 2019, 25 (23) :7046-7057